{"transactions":[{"id":802526,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-04-22T16:16:19.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":25900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 20, 2026 (the \"Grant Date\"), the Reporting Person was granted stock options to purchase 25,900 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date."}],"balance_after":25900,"derivative":{"exercise_price":2.36,"expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":25900},"source":{"system":"sec-edgar","filing":"0001104659-26-046833","document":"tm2612397-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465926046833/tm2612397-1_4seq1.xml","form_type":"4"}},{"id":1280009,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-06T17:47:58.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":145500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2025, the Reporting Person was granted stock options to purchase 145,500 shares of the Issuer's common stock. These options vest immediately."}],"balance_after":145500,"derivative":{"exercise_price":0.7982,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":145500},"source":{"system":"sec-edgar","filing":"0001104659-25-010181","document":"tm255798-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465925010181/tm255798-3_4seq1.xml","form_type":"4"}},{"id":1548639,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-04-03T21:56:25.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2024 (the \"Grant Date\"), the Reporting Person was granted stock options to purchase 145,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":145000,"derivative":{"exercise_price":3.15,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001104659-24-043292","document":"tm2411025-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465924043292/tm2411025-3_4seq1.xml","form_type":"4"}},{"id":1992327,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-24T16:32:18.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 13, 2023 (the \" Grant Date\"), the Reporting Person was granted stock options to purchase 75,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":75000,"derivative":{"exercise_price":3.41,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-23-025335","document":"tm237745-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465923025335/tm237745-3_4seq1.xml","form_type":"4"}},{"id":2640474,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-07-06T16:06:23.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 1, 2021 (the \"Employment Agreement Grant Date\"), the Reporting Person was granted stock options to purchase 200,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's Chief Financial Officer pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024."}],"balance_after":200000,"derivative":{"exercise_price":6.18,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-089393","document":"tm2121425-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465921089393/tm2121425-2_4seq1.xml","form_type":"4"}},{"id":2640473,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-07-06T16:06:23.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 29, 2021 (the \"June Grant Date\"), the Reporting Person was granted stock options to purchase 70,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person."}],"balance_after":70000,"derivative":{"exercise_price":6.26,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-21-089393","document":"tm2121425-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601121/000110465921089393/tm2121425-2_4seq1.xml","form_type":"4"}},{"id":3836508,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-08-22T21:05:22.000Z","date":"2018-08-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units vest on the first anniversary of the grant date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000921895-18-002458","document":"form410211008swh_08202018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/890821/000092189518002458/form410211008swh_08202018.xml","form_type":"4"}},{"id":3836507,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2018-08-22T21:05:22.000Z","date":"2018-08-20","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders of the Issuer occurring after August 16, 2018. The options will expire on the fifth anniversary of the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders of the Issuer occurring after August 16, 2018. The options will expire on the fifth anniversary of the vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.53,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000921895-18-002458","document":"form410211008swh_08202018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/890821/000092189518002458/form410211008swh_08202018.xml","form_type":"4"}},{"id":4348731,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":51601,"kind":"person","name":"Shawah Robert G.","position":1,"cik":"0001601121","reported_name":"Shawah Robert G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Options","published_at":"2017-04-20T06:31:34.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest as follows: options to purchase 65,000 shares of common stock vested on January 17, 2017; options to purchase 2,708 shares of common stock vest monthly in each of the 23 months after the date of grant and options to purchase 2,716 shares of common stock will vest on the 24th month anniversary of the date of grant."}],"balance_after":130000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001144204-17-021133","document":"v464469_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000114420417021133/v464469_4.xml","form_type":"4"}}]}